Europe's largest commercially- focused event for the rare disease industry
 |
 
|
Learn, partner, promote
World Orphan Drug Congress 2013 is a proven conference and exhibition bringing together buyers, sellers and key influencers from across the orphan and rare disease industry.
Having welcomed over 1000 orphan and rare disease stakeholders in only its 3 year history, the event in Europe’s logical choice for Biotech and Pharma orphan drug players who want to meet Rare Disease Networks, Patient Groups, COMP Members, HTA Experts, Regulators and Payers.
More on exhibiting ›
More on attending ›
The track record
- Over 280 pioneers and opinion leaders attended in 2012
- 71% of attendees were of pharma, biotech or academic origin
- 77% of attendees were C-Level, Executive, Director or Manager level
- 19+ countries represented onsite from across Europe, North America and Asia
- Over 1600 onsite 1-2-1 meetings facilitated
Learn and innovate
- 45+ speakers in 2013
- 35+ educational sessions
- 16+ roundtable discussions
- 3 super keynote sessions
- 2 parallel conference tracks and workshops
NEW for 2013:
- Patient / Advocacy Poster and Meeting Zone
- Biotech Poster Session Zone
More on exhibiting ›
More on attending ›
Pursue and partner
- 1750+ partnering meetings in 3 days
- 300+ companies in the Total BioPharma Partnering system
- 1-2-1 Speed Networking sessions
- 2 engaging networking lunches
- 1 social evening function
Raise and promote
Let us give you an edge
We offer different packages to suit your business needs.
If you’d like to become an exhibitor sponsor or speaker at next year’s event Call Ben Scales on +44 (0) 207 092 1185 or email ben.scales@terrapinn.com
Make an enquiry ›
Download more information ›
